Anebulo Pharmaceuticals, Inc. (ANEB)
ANEB Stock Price Chart
Explore Anebulo Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze ANEB price movements and trends.
ANEB Company Profile
Discover essential business fundamentals and corporate details for Anebulo Pharmaceuticals, Inc. (ANEB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
7 May 2021
Employees
2.00
Website
https://www.anebulo.comCEO
Richard Anthony Cunningham
Description
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.
ANEB Financial Timeline
Browse a chronological timeline of Anebulo Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 12 Feb 2026
Upcoming earnings on 24 Sept 2025
EPS estimate is -$0.05.
Earnings released on 13 May 2025
EPS came in at -$0.04 surpassing the estimated -$0.05 by +20.00%.
Earnings released on 14 Feb 2025
EPS came in at -$0.09 falling short of the estimated -$0.08 by -12.50%.
Earnings released on 13 Nov 2024
EPS came in at -$0.08 falling short of the estimated -$0.05 by -60.00%.
Earnings released on 25 Sept 2024
EPS came in at -$0.05 surpassing the estimated -$0.13 by +61.54%.
Earnings released on 15 May 2024
EPS came in at -$0.06 surpassing the estimated -$0.11 by +45.45%.
Earnings released on 13 Feb 2024
EPS came in at -$0.11 matching the estimated -$0.11.
Earnings released on 14 Nov 2023
EPS came in at -$0.10 surpassing the estimated -$0.11 by +9.09%.
Earnings released on 20 Sept 2023
EPS came in at -$0.10 matching the estimated -$0.10.
Earnings released on 11 May 2023
EPS came in at -$0.11 surpassing the estimated -$0.16 by +31.25%.
Earnings released on 10 Feb 2023
EPS came in at -$0.15 falling short of the estimated -$0.11 by -36.36%.
Earnings released on 10 Nov 2022
EPS came in at -$0.11 falling short of the estimated -$0.10 by -10.00%.
Earnings released on 9 Sept 2022
EPS came in at -$0.10 falling short of the estimated -$0.07 by -42.86%.
Earnings released on 11 May 2022
EPS came in at -$0.08 falling short of the estimated -$0.05 by -60.00%.
Earnings released on 11 Feb 2022
EPS came in at -$0.05 surpassing the estimated -$0.06 by +16.67%.
Earnings released on 12 Nov 2021
EPS came in at -$0.07 .
Earnings released on 22 Sept 2021
EPS came in at -$0.13 falling short of the estimated -$0.00 by -5.21K%.
Earnings released on 10 May 2021
EPS came in at -$0.02 surpassing the estimated -$0.04 by +40.28%.
Earnings released on 6 May 2021
EPS came in at -$0.01 .
Earnings released on 30 Sept 2020
EPS came in at -$0.01 .
ANEB Stock Performance
Access detailed ANEB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.